<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01484223</url>
  </required_header>
  <id_info>
    <org_study_id>FIS PI08/90707</org_study_id>
    <nct_id>NCT01484223</nct_id>
  </id_info>
  <brief_title>Effectiveness of Cognitive Behavioral Intervention in Patients With Symptoms Somatization in Primary Care</brief_title>
  <official_title>Efectiveness of a Cognitive Behavioral Intervention in Patients With Symptoms Somatization, as Measure Quality of Life, Front the Clinical Practice Usual Action in Primary Health Care. A Controlled Clinical Trial With Parallel Groups</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gerencia de Atención Primaria, Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondo de Investigacion Sanitaria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gerencia de Atención Primaria, Madrid</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efectiveness of a behavioral cognitive grupal&#xD;
      intervention (BCI) in patients with somatization symptoms which has an effect on the&#xD;
      perceived quality of life front conventional intervention.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim: to determine whether a cognitive-behavioral group intervention in patients with&#xD;
      unexplicated somatic symptoms, that have come to the primary care medical in Madrid, is more&#xD;
      effective than normal practice in terms of improving life quality at one year.&#xD;
&#xD;
      Method:&#xD;
&#xD;
      Design:cluster randomized trial. Setting: study in Health Centers Primary Care of Area of&#xD;
      Madrid Health Service. unit of randomization are centres.Analysis unit: patients between 18&#xD;
      and 65 years old.&#xD;
&#xD;
      Intervention: The cognitive behavioral grupal Terapy in the internention group and the usual&#xD;
      intervention in the control group.&#xD;
&#xD;
      Sample size adjusted for design effect=242 (121 in each arm). Main response variable:&#xD;
      preceived quality of life (SF-12).&#xD;
&#xD;
      Data Analysis:comparison of the proportion of patients that improve in 4 or more points in&#xD;
      the area of Mental Healthcare from the SF-12 in both groups,at 6 months and 1 year after&#xD;
      patient inclusion.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perceived quality of life</measure>
    <time_frame>Change from baseline in quality of life at 12 months after the intervention</time_frame>
    <description>Perceived quality of life: Quality of life measured by SF-12 questionnare on Mental Healthcare Change from baseline in quality of life at 3, 6 and 12 months after the intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Questionnarie on Global Clinical Impression</measure>
    <time_frame>Change from baseline in patient and doctor´s perception at 12 months afer the intervention</time_frame>
    <description>It is used to assess the patient´s(PGI questionnarie) and the doctor´s(CGI questionnarie)perception on the former´s improvement after the interventions have been carried out. It will be undertaken 6 and 12 moths later, so as to assess the effectiveness of the group intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of examinations</measure>
    <time_frame>Number of examinations from baseline until 12 months after the intervention</time_frame>
    <description>Number of requested and programmed doctor´s examinations during the period of study (itemized between infirmary and medicine)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prescribed medicine</measure>
    <time_frame>Prescribed medicine from baseline until 12 months after the intervention</time_frame>
    <description>Prescribed medicine during the period of study, with doubtful therapeutic value for their processing, related to the unexplained somatic symptoms. The included medicines are those related to the functional symptomatology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Temporary labor disability (TLD)</measure>
    <time_frame>Days on TLD from baseline until 12 months after the intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">242</enrollment>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention group: Structured nursing intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group: conventional intervention or non_support</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy</intervention_name>
    <description>Four Cognitive behavioral group sessions. Each session will last two hours a week</description>
    <arm_group_label>Experimental Group</arm_group_label>
    <other_name>Primary Health Care</other_name>
    <other_name>Somatization symptoms</other_name>
    <other_name>Nursing intervention</other_name>
    <other_name>Quality of life</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Attending patients with 2 or more medically unexplained somatic symptoms during the&#xD;
             last 6 months.&#xD;
&#xD;
          -  Having came to medical examination on primary care at least 10 times during the last&#xD;
             year.&#xD;
&#xD;
          -  be able to follow the trial´s demands, not have plans for moving another place and&#xD;
             understand the Spanish language.&#xD;
&#xD;
          -  Patients who consent to take part.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnostics on serious mental disorder.&#xD;
&#xD;
          -  Suicidal intentions at the moment of getting involved in the study.&#xD;
&#xD;
          -  Diagnostics on addiction to toxic substances.&#xD;
&#xD;
          -  Diagnostics on well-known body illness responsible for the symptoms.&#xD;
&#xD;
          -  Previous psychotherapy during the previous year.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alberto López García-Franco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gerencia Atención Primaria. Madrid</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gerencia Atención Primaria, Madrid.</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <study_first_submitted>November 30, 2011</study_first_submitted>
  <study_first_submitted_qc>December 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2011</study_first_posted>
  <last_update_submitted>October 10, 2012</last_update_submitted>
  <last_update_submitted_qc>October 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gerencia de Atención Primaria, Madrid</investigator_affiliation>
    <investigator_full_name>Esperanza Escortell</investigator_full_name>
    <investigator_title>Epidemiologist</investigator_title>
  </responsible_party>
  <keyword>Primary Health Care</keyword>
  <keyword>Somatization symptoms</keyword>
  <keyword>Cognitive Behavioral Therapy</keyword>
  <keyword>Nursing intervention</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

